down arrow

Xylem, Inc.

  • Market Cap: Mid Cap
  • Industry: Industrial Manufacturing
  • ISIN: US98419M1009
USD
140.87
-0.02 (-0.01%)

Dec 04

NYS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationMojo Score Change: Xylem, Inc. has changed its score on 20 Nov 2025. Click here to unlock latest mojo score!
stock-summaryPrice Point
High/Low

1Day

140.09141.14

52 Week

100.47154.27
Valuation
Technical
Day's Volume

CASH

390.33 k

Shareholding (Mar 2025)

FII

38.70%

Held by 445 FIIs

DII

31.41%

Held by 57 DIIs

Promoter

0.00%

How big is Xylem, Inc.?

22-Jun-2025

As of Jun 18, Xylem, Inc. has a market capitalization of $32.41 billion, with recent net sales of $8.60 billion and a net profit of $904 million over the last four quarters.

Market Cap: As of Jun 18, Xylem, Inc. has a market capitalization of 32,414.54 million, categorizing it as a Large Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Xylem, Inc. reported net sales of 8,596.00 million and a net profit of 904.00 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 10,642.00 million and total assets of 16,493.00 million.

Read More

What does Xylem, Inc. do?

22-Jun-2025

Xylem, Inc. is a water technology company specializing in engineered solutions for water and wastewater applications, with recent net sales of $2.066 billion and a market cap of $32.41 billion. Key metrics include a P/E ratio of 35.00 and a dividend yield of 112.93%.

Overview:<BR>Xylem, Inc. is a water technology company operating in the industrial manufacturing sector, focusing on engineered solutions for water and wastewater applications.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 2,066 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 167 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 32,414.54 Million (Large Cap) <BR><BR>Key Metrics:<BR>P/E: 35.00 <BR>Dividend Yield: 112.93% <BR>Debt Equity: 0.10 <BR>Return on Equity: 8.64% <BR>Price to Book: 3.00 <BR><BR>Contact Details:<BR>Address: 1 International Dr, RYE BROOK NY: 10573 <BR>Tel: ['1 914 3235700', '1 914 3235821'] <BR>Fax: 1 914 3235800 <BR>Website: https://www.xylem.com/

Read More

Who are in the management team of Xylem, Inc.?

22-Jun-2025

As of March 2022, the management team of Xylem, Inc. includes Markos Tambakeras (Independent Chairman), Patrick Decker (CEO), and several independent directors: Jeanne Beliveau-Dunn, Curtis Crawford, Robert Friel, Jorge Gomez, and Victoria Harker. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Xylem, Inc. includes the following individuals:<BR><BR>- Mr. Markos Tambakeras, Independent Chairman of the Board<BR>- Mr. Patrick Decker, President, Chief Executive Officer, Director<BR>- Ms. Jeanne Beliveau-Dunn, Independent Director<BR>- Dr. Curtis Crawford, Independent Director<BR>- Mr. Robert Friel, Independent Director<BR>- Mr. Jorge Gomez, Independent Director<BR>- Ms. Victoria Harker, Independent Director<BR><BR>This team is responsible for overseeing the company's strategic direction and operations.

Read More

Is Xylem, Inc. technically bullish or bearish?

29-Sep-2025

As of September 26, 2025, Xylem, Inc. has a bullish technical trend with strong indicators, outperforming the S&P 500 year-to-date with a 23.28% return, although it has lagged in longer-term performance.

As of 26 September 2025, the technical trend for Xylem, Inc. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators: both weekly and monthly MACD are bullish, Bollinger Bands are bullish across both time frames, and daily moving averages are also bullish. The KST shows a bullish weekly trend but is mildly bearish monthly, while Dow Theory indicates a mildly bullish stance on both weekly and monthly bases. Despite the bullish outlook, the OBV is mildly bearish on a weekly basis. <BR><BR>In terms of performance, Xylem has outperformed the S&P 500 year-to-date with a return of 23.28% compared to the S&P 500's 12.96%, but it has lagged over longer periods, such as the 3-year and 5-year returns.

Read More

Is Xylem, Inc. overvalued or undervalued?

05-Nov-2025

As of October 31, 2025, Xylem, Inc. is considered expensive with a P/E ratio of 35 and other elevated metrics, despite a strong recent return of 29.02%, as its longer-term performance lags behind the S&P 500.

As of 31 October 2025, the valuation grade for Xylem, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value. The company appears to be overvalued based on its current metrics, with a P/E ratio of 35, a Price to Book Value of 3.03, and an EV to EBITDA of 20.21. In comparison, peers such as Ingersoll Rand, Inc. have a significantly higher P/E of 52.55, while Dover Corp. is at 43.35, suggesting that Xylem's valuation is not as extreme as some competitors but still elevated.<BR><BR>Despite a strong year-to-date return of 29.02% compared to the S&P 500's 16.30%, Xylem's longer-term performance has lagged behind, with a 5-year return of 63.40% versus the S&P 500's 109.18%. This discrepancy reinforces the notion that while Xylem has performed well recently, its current valuation may not be justified given its relative performance and the valuation metrics compared to its peers.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company has a low Debt to Equity ratio (avg) at times

 
2

Low Debt Company with Strong Long Term Fundamental Strength

 
3

The company has declared Positive results for the last 7 consecutive quarters

4

With ROCE of 9.26%, it has a expensive valuation with a 2.84 Enterprise value to Capital Employed

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Industrial Manufacturing

stock-summary
Market cap

USD 36,213 Million (Mid Cap)

stock-summary
P/E

35.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

103.74%

stock-summary
Debt Equity

0.09

stock-summary
Return on Equity

8.72%

stock-summary
Price to Book

3.27

Revenue and Profits:
Net Sales:
2,303 Million
(Quarterly Results - Jun 2025)
Net Profit:
224 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.75%
0%
-0.75%
6 Months
11.16%
0%
11.16%
1 Year
10.45%
0%
10.45%
2 Years
32.31%
0%
32.31%
3 Years
24.08%
0%
24.08%
4 Years
19.29%
0%
19.29%
5 Years
43.15%
0%
43.15%

Xylem, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News

Is Xylem, Inc. overvalued or undervalued?

As of 31 October 2025, the valuation grade for Xylem, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value. The company appears to be overvalued based on its current metrics, with a P/E ratio of 35, a Price to Book Value of 3.03, and an EV to EBITDA of 20.21. In comparison, peers such as Ingersoll Rand, Inc. have a significantly higher P/E of 52.55, while Dover Corp. is at 43.35, suggesting that Xylem's valuation is not as extreme as some competitors but still elevated. Despite a strong year-to-date return of 29.02% compared to the S&P 500's 16.30%, Xylem's longer-term performance has lagged behind, with a 5-year return of 63.40% versus the S&P 500's 109.18%. This discrepancy reinforces the notion that while Xylem has performed well recently, its current valuation may not be justified given its relative performance and the valuation metrics compared to its pee...

Read More

Is Xylem, Inc. overvalued or undervalued?

As of 31 October 2025, the valuation grade for Xylem, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value. Despite this change, the company appears to be overvalued based on its current metrics. Key ratios include a P/E ratio of 35, an EV to EBITDA of 20.21, and a Price to Book Value of 3.03, all of which suggest that the stock is trading at a premium compared to its peers. In comparison, Ingersoll Rand, Inc. has a higher P/E ratio of 52.55, while Dover Corp. is more fairly valued with a P/E of 43.35. This places Xylem in a relatively expensive position within its industry. Additionally, while Xylem has shown strong returns, with a year-to-date return of 30.02% compared to the S&P 500's 16.30%, its three-year return of 47.27% lags behind the S&P 500's 76.66%. This performance suggests that, despite recent gains, the stock's valuation may not be justified in t...

Read More

Is Xylem, Inc. overvalued or undervalued?

As of 31 October 2025, the valuation grade for Xylem, Inc. has moved from very expensive to expensive, indicating a slight improvement in perceived value. However, the company remains overvalued based on its current metrics. The P/E ratio stands at 35, significantly higher than the industry average, while the EV to EBITDA ratio is 20.21, and the PEG ratio is 1.10, suggesting that the stock is priced for growth that may not materialize. In comparison to its peers, Xylem, Inc. has a P/E ratio of 37.49, which is higher than Dover Corp.'s fair valuation at 43.35 and significantly lower than Ingersoll Rand, Inc.'s very expensive rating at 52.55. The company's recent performance shows a 30.02% return year-to-date, outperforming the S&P 500's 16.30% in the same period, but it lags behind the S&P 500 over longer horizons, particularly in the 3-year and 5-year returns. Overall, Xylem, Inc. appears to be overvalued ...

Read More
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
11.99%
EBIT Growth (5y)
14.44%
EBIT to Interest (avg)
9.14
Debt to EBITDA (avg)
1.27
Net Debt to Equity (avg)
0.10
Sales to Capital Employed (avg)
0.66
Tax Ratio
18.41%
Dividend Payout Ratio
39.40%
Pledged Shares
0
Institutional Holding
99.57%
ROCE (avg)
11.32%
ROE (avg)
11.08%
Valuation key factors
Factor
Value
P/E Ratio
35
Industry P/E
Price to Book Value
3.03
EV to EBIT
30.73
EV to EBITDA
20.21
EV to Capital Employed
2.84
EV to Sales
3.94
PEG Ratio
1.10
Dividend Yield
111.76%
ROCE (Latest)
9.26%
ROE (Latest)
8.64%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 150 Schemes (29.87%)

Foreign Institutions

Held by 445 Foreign Institutions (38.7%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 11.47% vs -8.50% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 34.13% vs -48.77% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,303.00",
          "val2": "2,066.00",
          "chgp": "11.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "477.00",
          "val2": "393.00",
          "chgp": "21.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18.00",
          "val2": "19.00",
          "chgp": "-5.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-17.00",
          "val2": "-10.00",
          "chgp": "-70.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "224.00",
          "val2": "167.00",
          "chgp": "34.13%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "144.20%",
          "val2": "120.00%",
          "chgp": "2.42%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.23% vs 32.95% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 46.14% vs 71.55% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "8,563.00",
          "val2": "7,367.00",
          "chgp": "16.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,635.00",
          "val2": "1,171.00",
          "chgp": "39.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "76.00",
          "val2": "79.00",
          "chgp": "-3.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-30.00",
          "val2": "-46.00",
          "chgp": "34.78%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "890.00",
          "val2": "609.00",
          "chgp": "46.14%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "125.30%",
          "val2": "99.80%",
          "chgp": "2.55%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
2,303.00
2,066.00
11.47%
Operating Profit (PBDIT) excl Other Income
477.00
393.00
21.37%
Interest
18.00
19.00
-5.26%
Exceptional Items
-17.00
-10.00
-70.00%
Consolidate Net Profit
224.00
167.00
34.13%
Operating Profit Margin (Excl OI)
144.20%
120.00%
2.42%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is 11.47% vs -8.50% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 34.13% vs -48.77% in Mar 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
8,563.00
7,367.00
16.23%
Operating Profit (PBDIT) excl Other Income
1,635.00
1,171.00
39.62%
Interest
76.00
79.00
-3.80%
Exceptional Items
-30.00
-46.00
34.78%
Consolidate Net Profit
890.00
609.00
46.14%
Operating Profit Margin (Excl OI)
125.30%
99.80%
2.55%
USD in Million.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 16.23% vs 32.95% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 46.14% vs 71.55% in Dec 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Xylem, Inc. stock-summary
stock-summary
Xylem, Inc.
Industrial Manufacturing
Xylem Inc. is a water technology company. The Company designs, manufactures and services engineered solutions across a range of critical applications. It is an equipment and service provider for water and wastewater applications with a portfolio of products and services addressing the cycle of water, from collection, distribution and use to the return of water to the environment. It has three business segments, which include Water Infrastructure, Applied Water and Sensus. Water Infrastructure focuses on the transportation, treatment and testing of water, offering a range of products, including water and wastewater pumps, and controls and systems. Applied Water serves the uses of water and focuses on the residential, commercial, industrial and agricultural markets. The Sensus segment's products include metering, networked communications, measurement and control technologies, software and services, including cloud-based analytics, remote monitoring and data management.
Company Coordinates stock-summary
Company Details
1 International Dr , RYE BROOK NY : 10573
stock-summary
Tel: 1 914 32357001 914 3235821
stock-summary
https://www.xylem.com/
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."